XML 133 R111.htm IDEA: XBRL DOCUMENT v3.24.0.1
Schedule I - Balance Sheets (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Accounts receivable        
Other, net $ 19,296 $ 6,684    
Prepaid assets 64,387 84,759    
Other current assets 10,389 1,917    
Total current assets 422,175 367,829    
Other long-term assets:        
Investments in subsidiaries 146,049 1,745    
Total assets 4,816,309 3,058,626    
Current liabilities:        
Accounts payable 84,193 128,174    
Accrued liabilities 227,690 219,769    
Other current liabilities 48,769 60,359    
Total current liabilities 578,615 607,058    
Long-term liabilities:        
Other long-term liabilities 251,278 176,152    
Total liabilities 2,661,158 1,893,050    
Commitments and contingencies    
Stockholdersʼ Equity:        
Preferred stock; $0.01 par value; 30,000,000 shares authorized and zero shares issued or outstanding as of December 31, 2023 and 2022, respectively 0 0    
Common stock; $0.01 par value; 270,000,000 shares authorized; 127,480,361 and 82,570,328 shares issued as of December 31, 2023 and 2022, respectively 1,275 826    
Additional paid-in capital 2,549,097 1,699,799    
Accumulated deficit (347,717) (535,049)    
Treasury stock, at cost; 3,400,000 and zero shares as of December 31, 2023 and 2022, respectively (47,504) 0    
Total stockholdersʼ equity 2,155,151 1,165,576 $ 760,653 $ 926,601
Total liabilities and stockholdersʼ equity 4,816,309 3,058,626    
Parent        
Accounts receivable        
Other, net 100 0    
Prepaid assets 221 169    
Other current assets 19 36    
Total current assets 340 205    
Other long-term assets:        
Investments in subsidiaries 2,246,908 1,168,053    
Total assets 2,247,248 1,168,258    
Current liabilities:        
Accounts payable 316 249    
Accrued liabilities 705 728    
Other current liabilities 124 62    
Total current liabilities 1,145 1,039    
Long-term liabilities:        
Other long-term liabilities 90,952 1,643    
Total liabilities 92,097 2,682    
Commitments and contingencies    
Stockholdersʼ Equity:        
Preferred stock; $0.01 par value; 30,000,000 shares authorized and zero shares issued or outstanding as of December 31, 2023 and 2022, respectively 0 0    
Common stock; $0.01 par value; 270,000,000 shares authorized; 127,480,361 and 82,570,328 shares issued as of December 31, 2023 and 2022, respectively 1,275 826    
Additional paid-in capital 2,549,097 1,699,799    
Accumulated deficit (347,717) (535,049)    
Treasury stock, at cost; 3,400,000 and zero shares as of December 31, 2023 and 2022, respectively (47,504) 0    
Total stockholdersʼ equity 2,155,151 1,165,576    
Total liabilities and stockholdersʼ equity $ 2,247,248 $ 1,168,258